首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

International Journal Of Clinical Pharmacology And Therapeutics

International Journal Of Clinical Pharmacology And Therapeutics杂志,由Dustri-Verlag Dr. Karl Feistle出版,于1994年创刊,Monthly,出版语言English,ISSN:0946-1965,E-ISSN:0946-1965。

投稿咨询
International Journal Of Clinical Pharmacology And Therapeutics
International Journal Of Clinical Pharmacology And Therapeutics
International Journal Of Clinical Pharmacology And Therapeutics
SCI SCIE

杂志介绍

JCR分区
Q4
中科院分区
4区
影响因子
0.9
CiteScore
1.5
期刊收录
SCI、SCIE

International Journal Of Clinical Pharmacology And Therapeutics(中文译名:《国际临床药理学和治疗学杂志》),ISSN:0946-1965,EISSN:0946-1965,是Dustri-Verlag Dr. Karl Feistle出版的国际性学术期刊,创刊于1994年,以Monthly形式稳定发行,2026年总发文量约83篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达0.9,2025年期刊CiteScore为1.5,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。International Journal Of Clinical Pharmacology And Therapeutics长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q4 321 / 356

10

学科:PHARMACOLOGY & PHARMACY SCIE Q4 309 / 356

13.34

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q4 324 / 352

8.1

学科:PHARMACOLOGY & PHARMACY SCIE Q4 303 / 353

14.31


中国学者近期发文

1
Prediction of paclitaxel-induced myelosuppression: Validation of a regression model using creatinine clearance and other risk factors obtained retrospectively in hospitalized cancer patient

Author:Hai, Yang; Liu, Yulong

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. 64, Issue 5, pp. 259-268. DOI: 10.5414/CP204939

2
Systemic bismuth absorption and safety of the gastric mucosal protective bismuth potassium citrate, administered as granules and tablets in healthy Chinese and validation of a new, ICP-MS bismuth assa

Author:Lv, Xiaozhi; Wu, Junyan; Ye, Suiwen; Wang, Quansheng; Gan, Shuguang; Pi, Jianbin; Xiong, Yongjian; Zhang, Nan

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.5414/CP204626

3
Beneficial effects of dexmedetomidine with sevoflurane inhalation in abdominal surgery: Quality of anesthesia, intestinal flora, and serum pain mediator

Author:Pan, Qiaoying; Mao, Libin; Lv, Qinglin

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.5414/CP204908

4
Postoperative infusion of dexmedetomidine for the prevention of postoperative delirium in elderly patients undergoing lung surgery: A randomized controlled tria

Author:Li, Fujing; Zhang, Weizhou; Huo, Jian; Cheng, Liming; Zhao, Rui

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.5414/CP204731

5
Iodixanol-induced acute kidney injury and multi-organ complications via alternative excretion: A case report and mechanism exploratio

Author:Li, Le; Yang, Lifang; Wu, Huifeng; Chen, Lin; Jiang, Zhouqian

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.5414/CP204941

6
Network pharmacology and bioinformatics analysis of the multi-target immune-inflammatory mechanisms of Shengma Gegen decoction in chronic urticari

Author:Hu, Miao; Ma, Yirong; Li, Jiaming; Wu, Jianguang

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.5414/CP204855

7
Acute arsenic poisoning from realgar water: Case series from Guilin, Chin

Author:Fu, Yong-Fei; Xu, Hong-Zhen; Long, Xin; Liao, Qian-Qian; Huang, Hai-Ling; Deng, Kun; Jiang, Yan-Juan; Tang, Guo-Rong; Tang, Shu-Ping; Tang, Jian; Qin, Dong

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.5414/CP204830

8
Epidemiological characteristics of severe skin adverse reactions caused by immune checkpoint inhibitors based on case report

Author:Tang, Su-na; Ma, Xiao-wen; Zhang, Xiao-yan; Zhang, Na-na; Wang, Fei; Ye, Feng-lin; Chen, Na-na; Yang, Ping; Zhu, Ning-ning

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.5414/CP204826

9
Impact of extracorporeal membrane oxygenation on antituberculosis drug concentrations: A case study and pharmaceutical care strategie

Author:Xu, Yidan; Lv, Fei; Yu, Xing

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.5414/CP204865

10
Bioequivalence of two doxorubicin liposome formulations (LY01612 and Caelyx) using free and encapsulated doxorubicin concentrations in Chinese patients with advanced breast cance

Author:Zhang, Lina; Geng, Cuizhi; Wang, Mingxia; Chen, Wenyan; Li, Fanfan; Wang, Xicheng; Wang, Xinshuai; Zang, Aimin; Niu, Zhaofeng; Zhao, Fengli; Yang, Hui; Sun, Hongliang; Song, Hongtao; Liu, Wanhui; Yu, Fei; Jia, Xianglei; Tong, Jin; Che, Xin; Bai, Lingying; Deng, Xuetao

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2025; Vol. , Issue , pp. -. DOI: 10.5414/CP204653


在线咨询

International Journal Of Clinical Pharmacology And Therapeutics

国际简称:INT J CLIN PHARM TH参考译名:国际临床药理学和治疗学杂志

年发文量:83 CiteScore:1.5 是否预警:否 Gold OA文章占比:0.00% 研究类文章占比:92.77%

杂志社联系方式:DUSTRI-VERLAG DR KARL FEISTLE, BAHNHOFSTRASSE 9 POSTFACH 49, DEISENHOFEN-MUENCHEN, GERMANY, D-82032

International Journal Of Clinical Pharmacology And Therapeutics